approval
saveIMDELLTRA (TARLATAMAB-DLLE) — FDA approval
community read0 votes
Sponsor: AMGEN INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 1
same company · ±60 days · 6
- approvaleculizumab biosimilar: BKEMV (ECULIZUMAB-AEEB) — FDA approvalNov 24, 2025
- approvalENBREL (ETANERCEPT) — FDA approvalDec 10, 2025
- approvalblinatumomab: BLINCYTO (BLINATUMOMAB) — FDA approvalOct 21, 2025
- approvalAMJEVITA: AMJEVITA (ADALIMUMAB-ATTO) — FDA approvalOct 16, 2025
- approvalapremilast: OTEZLA (APREMILAST) — FDA approvalDec 23, 2025
- approvalWEZLANA: WEZLANA (USTEKINUMAB-AUUB) — FDA approvalSep 25, 2025
comments(0)
5-min edit window · permanent after that